febuxostat has been researched along with cytochrome c-t in 1 studies
| Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (cytochrome c-t) | Trials (cytochrome c-t) | Recent Studies (post-2010) (cytochrome c-t) |
|---|---|---|---|---|---|
| 818 | 133 | 710 | 11,809 | 21 | 5,125 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, A; Li, Y; Song, X; Wang, S; Wang, X; Yang, P; Zhao, C | 1 |
1 other study(ies) available for febuxostat and cytochrome c-t
| Article | Year |
|---|---|
Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis.
Topics: Animals; Animals, Newborn; Apoptosis; Caspase 3; Caspase 9; Cytochromes c; Febuxostat; Heart Function Tests; Heart Ventricles; Hypoxia; Male; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mitochondria; Models, Biological; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Necrosis; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction | 2015 |